Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.79 USD | +1.75% | -3.09% | +16.44% |
05-08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.44% | 3.11B | |
+29.43% | 48.16B | |
-1.26% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.10% | 25.59B | |
-22.95% | 18.96B | |
+7.87% | 12.92B | |
+29.14% | 12.03B | |
-1.94% | 11.77B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- JPMorgan Raises IDEAYA Biosciences' Price Target to $35 From $32, Maintains Overweight Rating